More is not necessarily better when treating Hodgkin's lymphoma
- PMID: 21990411
- DOI: 10.1200/JCO.2011.37.1377
More is not necessarily better when treating Hodgkin's lymphoma
Comment in
-
On the role of consolidation radiotherapy in advanced-stage Hodgkin's lymphoma.J Clin Oncol. 2012 Apr 1;30(10):1146-7; author reply 1147. doi: 10.1200/JCO.2011.41.2627. Epub 2012 Feb 27. J Clin Oncol. 2012. PMID: 22370311 No abstract available.
Comment on
-
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.J Clin Oncol. 2011 Nov 10;29(32):4234-42. doi: 10.1200/JCO.2010.33.9549. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990399 Clinical Trial.
-
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.J Clin Oncol. 2011 Nov 10;29(32):4227-33. doi: 10.1200/JCO.2010.30.9799. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990405 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
